Search Browse Earnings

Panbela Therapeutics, Inc. — SlamSEC

Panbela Therapeutics, Inc.

Pharmaceutical Preparations·WACONIA, MN

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$973,813

-21.0% YoY

FY 2014

Adj. EBITDA

-$34.1M

-3500.1% margin

FY 2023

Net Income

-$34.9M

-3587.2% margin

FY 2023

EPS (Diluted)

$0.17

FY 2013

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$1.3M

FY 2023

Total Debt

$5.4M

FY 2023

Net Debt

$4.2M

FY 2023

Enterprise Value

—

Debt / EBITDA

-0.1x

FY 2014

EV / EBITDA

—

Employees

—

CEO

Simpson Jennifer K.

CFO

Horvath Susan